Apellis Pharmaceuticals Ownership | Who Owns Apellis Pharmaceuticals?
Apellis Pharmaceuticals Ownership Summary
Apellis Pharmaceuticals is owned by 104.37% institutional investors, 13.62% insiders. Avoro capital advisors is the largest institutional shareholder, holding 9.70% of APLS shares. Vanguard Health Care Inv is the top mutual fund, with 4.94% of its assets in Apellis Pharmaceuticals shares.
APLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Apellis Pharmaceuticals | 104.37% | 13.62% | -17.99% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Avoro capital advisors | 12.22M | 9.70% | $211.57M |
| Ecor1 capital | 11.89M | 9.60% | $379.44M |
| Wellington management group llp | 11.80M | 9.52% | $376.57M |
| Vanguard group | 10.05M | 8.11% | $320.57M |
| Deep track capital, lp | 7.00M | 5.55% | $121.17M |
| Blackrock funding, inc. /de | 6.40M | 5.08% | $110.87M |
| Blackrock | 5.80M | 4.71% | $222.31M |
| State street | 4.53M | 3.65% | $144.40M |
| Suvretta capital management | 2.88M | 2.28% | $49.82M |
| Marshall wace, llp | 2.70M | 2.15% | $46.82M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ecor1 capital | 11.89M | 14.35% | $379.44M |
| Deep track capital, lp | 7.00M | 3.89% | $121.17M |
| Avoro capital advisors | 12.22M | 3.71% | $211.57M |
| Boxer capital | 1.73M | 3.49% | $66.21M |
| Siren | 2.58M | 2.31% | $44.63M |
| Ghost tree capital | 135.00K | 1.62% | $5.18M |
| Suvretta capital management | 2.88M | 1.50% | $49.82M |
| Artal group | 1.47M | 1.43% | $56.28M |
| Camber capital management lp | 850.00K | 1.38% | $14.71M |
| Braidwell lp | 1.12M | 0.66% | $19.41M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Marshall wace, llp | 2.70M | 0.05% | 2.68M |
| Ubs group | 2.59M | 0.02% | 2.27M |
| Deep track capital, lp | 7.00M | 3.89% | 2.00M |
| Royal bank of canada | 1.52M | 0.01% | 1.38M |
| Amundi | 1.60M | 0.01% | 1.27M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 11.80M | 0.07% | -3.77M |
| Jpmorgan chase | 411.55K | 0.00% | -3.47M |
| Octagon capital advisors lp | - | - | -3.01M |
| Fiera capital | - | - | -1.35M |
| Cibc world markets | - | - | -1.29M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.09M | 0.00% | 1.09M | $34.66M |
| Camber capital management lp | 850.00K | 1.38% | 850.00K | $14.71M |
| Bank of nova scotia | 594.81K | 0.02% | 594.81K | $10.30M |
| Ossiam | 555.95K | 0.11% | 555.95K | $9.62M |
| Capitolis liquid global markets | 544.60K | 0.07% | 544.60K | $9.43M |
Sold Out
| Holder | Change |
|---|---|
| Jfs wealth advisors | -1.00 |
| Concourse financial group securities | -1.00 |
| Creative financial designs inc /adv | -5.00 |
| Fortitude family office | -6.00 |
| Corecap advisors | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 273 | -0.36% | 131,534,068 | 4.01% | 104 | 1.03% | 151 | 11.03% | 69 | -13.75% |
| Mar 31, 2025 | 6 | -97.89% | 12,635,786 | -90.03% | 10 | 0.10% | 2 | -98.73% | 1 | -98.68% |
| Dec 31, 2024 | 99 | -66.10% | 25,361,392 | -78.34% | 20 | 0.23% | 57 | -59.57% | 27 | -71.28% |
| Sep 30, 2024 | 291 | 2.46% | 117,076,868 | 1.49% | 94 | 1.09% | 142 | -12.35% | 93 | 43.08% |
| Jun 30, 2024 | 284 | -13.41% | 115,360,815 | 2.98% | 93 | 1.12% | 162 | -2.41% | 65 | -32.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 6.24M | 4.94% | -3.04M |
| Vanguard Total Stock Mkt Idx Inv | 3.36M | 2.66% | -70.87K |
| Vanguard US Total Market Shares ETF | 3.30M | 2.63% | 2.68K |
| Vanguard Small Cap Index | 2.59M | 2.05% | -16.82K |
| SPDR® S&P Biotech ETF | 1.75M | 1.38% | 43.06K |
| Vanguard Small Cap Growth Index Inv | 1.47M | 1.16% | -725.00 |
| JPM US Mid Cap Growth-Composite | 1.30M | 1.07% | 294.66K |
| Polar Capital Biotech S Inc | 1.35M | 1.07% | - |
| JPMorgan Mid Cap Growth I | 1.30M | 1.05% | - |
| DWS Vermögensbildungsfonds I LD | 1.32M | 1.05% | -6.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 18, 2025 | Watson David O. | General Counsel | Sell | $139.00K |
| Jul 17, 2025 | Francois Cedric | Chief Executive Officer | Sell | $398.73K |
| Jul 16, 2025 | Watson David O. | General Counsel | Sell | $97.75K |
| Jul 15, 2025 | Francois Cedric | Chief Executive Officer | Sell | $38.17K |
| Jul 14, 2025 | Francois Cedric | Chief Executive Officer | Sell | $2.77M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 43 |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 4 |
APLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools